CLBT
Cellebrite DI
11.30$
+3.0%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 20.8% | 19.4% | 17.3% | 18.7% | 16.4% | 15.6% | 15.8% | |
| 79.2% | 80.6% | 82.7% | 81.3% | 83.6% | 84.4% | 84.2% | |
| 27.1% | 27.9% | 26.6% | 29.8% | 26.0% | 24.5% | 23.9% | |
| 16.7% | 15.3% | 19.5% | 15.1% | 13.4% | 12.7% | 13.7% | |
| 80.0% | 75.8% | 77.1% | 80.9% | 73.4% | 70.2% | 70.2% | |
| -0.9% | 4.7% | 5.6% | 0.4% | 10.2% | 14.2% | 14.0% | |
| 0.2% | 0.7% | 0.1% | 0.1% | 0.0% | 87.2% | 0.1% | |
| 0.8% | 5.8% | 33.4% | 44.6% | -23.2% | -68.8% | 19.1% | |
| 1.9% | 2.9% | 4.4% | 0.0% | 1.7% | 1.8% | 2.6% | |
| -1.1% | 3.0% | 29.0% | 44.6% | -24.9% | -70.5% | 16.5% | |
| 3.3% | 8.9% | 36.3% | 48.1% | -20.1% | -66.1% | 21.7% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.